Intramuscular
| Category | Glossary |
|---|---|
| Also known as | IM, Intramuscular Definition, IM Injection |
| Last updated | 2026-04-13 |
| Reading time | 3 min read |
| Tags | glossaryadministrationinjectionterminology |
Definition
Intramuscular (abbreviated IM) is an anatomical and pharmacological term describing the delivery of a substance directly into skeletal muscle tissue. In peptide research, intramuscular injection is an administration route that deposits the peptide solution within the body of a large muscle, from which it is absorbed into systemic circulation through the muscle's rich capillary network.
The term derives from the Latin intra- (within) and musculus (muscle).
Anatomical Context
Skeletal muscle lies beneath the subcutaneous tissue layer and is separated from it by a fibrous layer called the fascia. Muscle tissue is highly vascularized — it contains a dense capillary network supplied by arterioles and drained by venules, providing efficient and relatively rapid absorption of injected substances into the bloodstream.
Common intramuscular injection sites include:
- Deltoid — the lateral aspect of the upper arm, used for smaller volume injections (up to 1-2 mL)
- Vastus lateralis — the outer aspect of the mid-thigh, suitable for self-injection and larger volumes
- Ventrogluteal — the hip region overlying the gluteus medius, preferred for larger volumes (up to 3-5 mL) due to the thick muscle mass and minimal risk of sciatic nerve injury
- Dorsogluteal — the upper outer quadrant of the buttock; historically common but now less preferred due to sciatic nerve proximity
Characteristics of IM Administration
Absorption
Intramuscular injection generally provides faster absorption than subcutaneous administration due to the higher blood flow through muscle tissue. The bioavailability of IM-injected peptides is typically high, often exceeding 80%. Absorption rate is influenced by:
- Local blood flow — increased by exercise, heat application, and massage
- Injection volume — larger volumes create a larger depot with more surface area for absorption
- Solubility of the compound — aqueous solutions are absorbed faster than oil-based or depot formulations
- Muscle activity — contraction and relaxation of the injected muscle promotes absorption
Injection Technique
IM injection requires longer needles than subcutaneous injection to penetrate through the skin and subcutaneous layer into the muscle body. Typical needle specifications are 22-25 gauge, 25-38 mm (1-1.5 inches) in length, though the appropriate length depends on the injection site, body composition, and subcutaneous tissue thickness.
A detailed procedural guide is available in the Intramuscular Injection methods article.
When IM Is Used for Peptides
While most research peptides are administered subcutaneously, intramuscular injection is sometimes preferred when:
- A faster onset of action is desired
- The injection volume exceeds what is comfortable subcutaneously (generally greater than 1 mL)
- The specific peptide has known better absorption or efficacy from muscle tissue
- Certain depot formulations are designed for intramuscular delivery
Comparison with Subcutaneous
| Feature | Intramuscular (IM) | Subcutaneous (SC) |
|---|---|---|
| Absorption speed | Faster | Slower, more sustained |
| Needle length | 25-38 mm | 8-12.7 mm |
| Needle gauge | 22-25G | 29-31G |
| Self-injection ease | More difficult | Easier |
| Volume capacity | Up to 3-5 mL | 0.5-2 mL typical |
| Pain level | Generally more | Generally less |
Related Terms
- Intramuscular Injection — procedural guide for IM injection technique
- Subcutaneous — the tissue layer above muscle used for most peptide injections
- Bioavailability — absorption efficiency from different routes
- Injection Site Rotation — systematic variation of injection locations
Related entries
- Bioavailability— The percentage of an administered compound that reaches systemic circulation in its active form, heavily influenced by the route of administration.
- Intranasal— A glossary definition of intranasal as it applies to peptide administration — delivery of peptide solutions through the nasal mucosa for systemic or central nervous system absorption.
- Subcutaneous— A glossary definition of subcutaneous as it applies to peptide administration — the tissue layer beneath the skin and above the muscle where most peptide injections are deposited.
- Injection Site Rotation— A guide to systematic injection site rotation for peptide administration, covering anatomical site selection, rotation patterns, tracking methods, and strategies to minimize tissue irritation.
- Intramuscular Injection— A method of delivering substances directly into skeletal muscle tissue, providing faster absorption than subcutaneous injection due to the rich blood supply of muscle, used for certain peptides and biologics.